Skip to main content

US ClosedU.S. Closed

CBIO: Crescent Biopharma, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and development of novel cancer therapies.

52W Range

48thpctl

Volume

0.47×avg

Market Cap

659.30MUSD

P/E Ratio

-2.3TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Crescent Biopharma, Inc.

CBIONASDAQ Capital Market·USD·Closed

Crescent Biopharma, Inc.

CBIONASDAQ·USD·Closed

$17.75

−0.06%

$17.75

−$0.01 (0.06%)

52W Range

48thpctl

Volume

0.47×avg

Mkt Cap

659.30MUSD

P/E

-2.3TTM

Div Yield

–ann